Biotech Values

[DewDiligence]

>IDIX – do you think that Novartis will seek a larger investment?<

I think NVS will buy out the 44% of IDIX it doesn’t already own at a nice premium for IDIX shareholders, but I have no idea when this will happen. NVS’ purchase of Alcon greatly reduced NVS’ liquidity and financial flexibility.